BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)

BCWORLD PHARM. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,164	5,444	6,996	4,032	2,756	10,681
Short-Term Investments	2,467	2,467	4,170	4,025	1,746	1,880
Cash & Short-Term Investments	5,631	7,911	11,166	8,058	4,503	12,561
Cash Growth	-14.66%	-29.14%	38.57%	78.97%	-64.15%	263.45%
Accounts Receivable	18,070	20,297	18,190	16,511	15,047	-
Other Receivables	644.91	589.67	648.15	1,267	880.31	-
Receivables	18,714	20,887	19,483	17,778	15,927	-
Inventory	19,926	14,844	17,096	16,787	16,147	15,370
Prepaid Expenses	1,003	911.85	250.24	406.41	363.9	-
Other Current Assets	14.46	3.72	91.07	579.46	294.04	15,133
Total Current Assets	45,290	44,558	48,086	43,609	37,235	43,063
Property, Plant & Equipment	118,710	120,985	125,628	130,119	132,370	125,500
Long-Term Investments	3,078	2,921	1,784	1,362	3,756	-
Other Intangible Assets	2,706	2,711	2,997	2,828	2,266	1,175
Long-Term Deferred Tax Assets	4,802	4,946	5,459	4,979	3,145	2,268
Other Long-Term Assets	191.21	192.37	157.07	154.27	586.78	4,919
Total Assets	174,776	176,313	184,111	183,051	179,358	176,925
Accounts Payable	7,072	3,872	4,232	4,067	2,686	-
Accrued Expenses	3,978	3,915	425.32	456.14	556.95	-
Short-Term Debt	61,002	68,606	58,216	46,050	39,730	-
Current Portion of Long-Term Debt	15,083	5,653	21,433	26,817	5,405	-
Current Portion of Leases	299.12	256.72	196.82	62.87	66.58	-
Current Income Taxes Payable	225.44	84.71	136.93	-	133.13	-
Other Current Liabilities	3,668	3,477	7,606	6,753	7,314	56,160
Total Current Liabilities	91,328	85,865	92,246	84,206	55,892	56,160
Long-Term Debt	9,500	13,917	11,570	21,170	43,686	-
Long-Term Leases	521.15	521.27	424.88	154.87	132.15	-
Other Long-Term Liabilities	-0	-0	0	0	-0	37,198
Total Liabilities	101,349	100,303	104,241	105,531	99,711	93,357
Common Stock	1,947	1,778	1,778	1,778	1,778	1,778
Additional Paid-In Capital	34,961	34,947	34,947	34,947	34,947	34,947
Retained Earnings	38,008	41,520	46,495	44,404	45,255	48,106
Treasury Stock	-1,539	-1,578	-1,578	-1,578	-771.62	-771.62
Comprehensive Income & Other	-0	-0	-0	-0	248.54	100.65
Total Common Equity	73,377	76,668	81,643	79,552	81,458	84,161
Minority Interest	49.92	-657.38	-1,774	-2,032	-1,811	-593.29
Shareholders' Equity	73,427	76,010	79,869	77,520	79,647	83,568
Total Liabilities & Equity	174,776	176,313	184,111	183,051	179,358	176,925
Total Debt	86,406	88,954	91,841	94,255	89,021	-
Net Cash (Debt)	-80,774	-81,043	-80,675	-86,197	-84,518	12,561
Net Cash Per Share	-8699.49	-8730.77	-8691.15	-9194.93	-8998.56	1341.96
Filing Date Shares Outstanding	8.44	9.28	9.28	9.28	9.39	9.39
Total Common Shares Outstanding	8.44	9.28	9.28	9.28	9.39	9.39
Working Capital	-46,038	-41,307	-44,161	-40,597	-18,658	-13,096
Book Value Per Share	8695.43	8259.46	8795.44	8570.17	8672.71	8960.53
Tangible Book Value	70,671	73,957	78,646	76,724	79,192	82,986
Tangible Book Value Per Share	8374.71	7967.44	8472.57	8265.56	8431.48	8835.45
Land	17,138	17,138	17,138	17,138	11,773	11,608
Buildings	68,942	70,030	71,974	73,792	51,199	56,229
Machinery	26,885	27,259	30,345	33,654	36,336	40,799
Construction In Progress	1,508	983.43	278.23	593.43	28,346	13,296

Source: S&P Global Market Intelligence. Standard template. Financial Sources.